Literature DB >> 24687827

Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma.

Yann Godbert1, Bénédicte Henriques de Figueiredo2, Françoise Bonichon2, Frédéric Chibon3, Isabelle Hostein2, Gaëlle Pérot2, Camille Dupin4, Agnès Daubech5, Genevieve Belleannée6, Audrey Gros6, Antoine Italiano2, Isabelle Soubeyran2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24687827     DOI： 10.1200/JCO.2013.49.6596

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  34 in total

Review 1.  Evolving molecularly targeted therapies for advanced-stage thyroid cancers.

Authors:  Keith C Bible; Mabel Ryder
Journal:  Nat Rev Clin Oncol       Date:  2016-03-01       Impact factor: 66.675

2.  Characterization of thyroid cancer driven by known and novel ALK fusions.

Authors:  Federica Panebianco; Alyaksandr V Nikitski; Marina N Nikiforova; Cihan Kaya; Linwah Yip; Vincenzo Condello; Abigail I Wald; Yuri E Nikiforov; Simion I Chiosea
Journal:  Endocr Relat Cancer       Date:  2019-11       Impact factor: 5.678

Review 3.  [Differentiated thyroid cancer].

Authors:  V Tiedje; K W Schmid; F Weber; A Bockisch; D Führer
Journal:  Internist (Berl)       Date:  2015-02       Impact factor: 0.743

4.  Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling.

Authors:  Saad A Khan; Bo Ci; Yang Xie; David E Gerber; Muhammad S Beg; Steven I Sherman; Maria E Cabanillas; Naifa L Busaidy; Barbara A Burtness; Andreas M Heilmann; Mark Bailey; Jeffrey S Ross; David J Sher; Siraj M Ali
Journal:  Head Neck       Date:  2019-02-13       Impact factor: 3.147

5.  Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion.

Authors:  Alyaksandr V Nikitski; Susan L Rominski; Mamta Wankhede; Lindsey M Kelly; Federica Panebianco; Guillermo Barila; Daniel L Altschuler; Yuri E Nikiforov
Journal:  Am J Pathol       Date:  2018-08-18       Impact factor: 4.307

6.  Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.

Authors:  Pierre Vanden Borre; Alexa B Schrock; Peter M Anderson; John C Morris; Andreas M Heilmann; Oliver Holmes; Kai Wang; Adrienne Johnson; Steven G Waguespack; Sai-Hong Ignatius Ou; Saad Khan; Kar-Ming Fung; Philip J Stephens; Rachel L Erlich; Vincent A Miller; Jeffrey S Ross; Siraj M Ali
Journal:  Oncologist       Date:  2017-02-16

7.  Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.

Authors:  Soeren Latteyer; Vera Tiedje; Katharina König; Saskia Ting; Lukas C Heukamp; Lydia Meder; Kurt Werner Schmid; Dagmar Führer; Lars Christian Moeller
Journal:  Endocrine       Date:  2016-10-01       Impact factor: 3.633

8.  Anaplastic thyroid carcinoma: changing trends of treatment strategies and associated overall survival.

Authors:  Sabine Wächter; C Vorländer; J Schabram; I Mintziras; I Fülber; J Manoharan; K Holzer; D K Bartsch; E Maurer
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-14       Impact factor: 2.503

Review 9.  Biologic and Clinical Perspectives on Thyroid Cancer.

Authors:  James A Fagin; Samuel A Wells
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

Review 10.  [Genetics of thyroid nodules and thyroid carcinoma].

Authors:  D Führer
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.